|
LOC100129387 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.76409997510297E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.17890039344582E-10 |
| Normal-vs-Stage2 |
1.9660399999899E-05 |
| Normal-vs-Stage3 |
1.74109948680723E-10 |
| Normal-vs-Stage4 |
1.07050002196019E-09 |
| Stage1-vs-Stage2 |
9.222200E-01 |
| Stage1-vs-Stage3 |
5.855300E-03 |
| Stage1-vs-Stage4 |
2.275600E-02 |
| Stage2-vs-Stage3 |
1.341980E-01 |
| Stage2-vs-Stage4 |
1.491220E-01 |
| Stage3-vs-Stage4 |
9.251200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.49735779331195E-12 |
| Normal-vs-AfricanAmerican |
1.156840E-03 |
| Normal-vs-Asian |
1.77989999960992E-07 |
| Caucasian-vs-AfricanAmerican |
4.159200E-01 |
| Caucasian-vs-Asian |
8.610800E-01 |
| AfricanAmerican-vs-Asian |
4.927200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.35710000301626E-08 |
| Normal-vs-Female |
1.90480964334938E-12 |
| Male-vs-Female |
5.851400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.9838999987829E-08 |
| Normal-vs-Age(41-60Yrs) |
9.21259957209486E-10 |
| Normal-vs-Age(61-80Yrs) |
2.21199947247896E-10 |
| Normal-vs-Age(81-100Yrs) |
3.88669999995539E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.964200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.054200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.289400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.280600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.619620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.406000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.80640002955812E-09 |
| Classical-VS-Follicular |
7.900400E-02 |
| Classical-VS-Other |
3.998600E-01 |
| Classical-VS-Normal |
1.33549999947746E-08 |
| Tall-VS-Follicular |
5.22809995295859E-09 |
| Tall-VS-Other |
5.768000E-02 |
| Tall-VS-Normal |
4.66293670342566E-15 |
| Follicular-VS-Other |
6.309400E-01 |
| Follicular-VS-Normal |
4.12499999999927E-05 |
| Other-VS-Normal |
1.691020E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06760000839756E-09 |
| Normal-vs-N1 |
1.5380999999981E-05 |
| N0-vs-N1 |
9.592200E-01 |
|
|
